By Cristina Gallardo
Grifols and Brookfield said they aren't in takeover talks, after a media report indicated the investment company had resumed discussions with the Grifols family--which controls the Spanish pharmaceutical company--about a possible deal.
"Brookfield is not, and has not been, in discussions with the company's board of directors with respect to a potential transaction," Brookfield said.
The investor said it maintains a general dialogue with Grifols's reference shareholders, but said there is no update since it decided against making a bid for the company in November.
Grifols's board said separately that it "has no knowledge" of talks regarding another attempt by Brookfield to acquire the company.
The statements came after Spanish news website El Confidencial reported, citing unnamed sources, that Brookfield had resumed talks with the Grifols family over a possible deal.
Shares in Grifols traded 6% higher at 8.63 euros in European afternoon trading, paring back gains of as much as 15% earlier in the session, after both Grifols and Brookfield issued their statements.
Write to Cristina Gallardo at cristina.gallardo@wsj.com
(END) Dow Jones Newswires
April 02, 2025 08:47 ET (12:47 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。